BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 35917259)

  • 21. A case of multiple sebaceous epithelioma: analysis of microsatellite instability.
    Ueda M; Wang Y; Sugimura H; Tamura S; Kondoh M; Ichihashi M
    J Dermatol; 1999 Mar; 26(3):178-82. PubMed ID: 10209926
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metastatic Prostatic Adenocarcinoma in Patient With Muir-Torre Syndrome Misdiagnosed as Metastatic Sebaceous Carcinoma: Case Report and Systematic Literature Review.
    Cattelan L; Abi-Rafeh J; Brimo F; Kazan R; Redpath M; Chergui M
    Am J Dermatopathol; 2020 Sep; 42(9):700-705. PubMed ID: 32568842
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Muir-torre syndrome with intriguing squamous lesions: a case report and review of the literature.
    Nishizawa A; Nakanishi Y; Sasajima Y; Yamazaki N; Yamamoto A
    Am J Dermatopathol; 2006 Feb; 28(1):56-9. PubMed ID: 16456327
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fordyce granules and hyperplastic mucosal sebaceous glands as distinctive stigmata in Muir-Torre syndrome patients: characterization with reflectance confocal microscopy.
    Ponti G; Meschieri A; Pollio A; Ruini C; Manfredini M; Longo C; Mandel VD; Ciardo S; Tomasi A; Giannetti L; Pellacani G
    J Oral Pathol Med; 2015 Aug; 44(7):552-7. PubMed ID: 25213213
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Multiple sebaceous tumors with colon cancer--Muir-Torre syndrome].
    Vajda A; Scharrer K; Baló-Banga JM
    Orv Hetil; 2003 May; 144(20):985-9. PubMed ID: 12830729
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sebaceous gland tumors of the eyelids and conjunctiva in the Muir-Torre syndrome: a clinicopathologic study of five cases and literature review.
    Rishi K; Font RL
    Ophthalmic Plast Reconstr Surg; 2004 Jan; 20(1):31-6. PubMed ID: 14752307
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A clinical scoring system to identify patients with sebaceous neoplasms at risk for the Muir-Torre variant of Lynch syndrome.
    Roberts ME; Riegert-Johnson DL; Thomas BC; Rumilla KM; Thomas CS; Heckman MG; Purcell JU; Hanson NB; Leppig KA; Lim J; Cappel MA
    Genet Med; 2014 Sep; 16(9):711-6. PubMed ID: 24603434
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Muir-Torre syndrome: role of the dermatopathologist in diagnosis.
    Curry ML; Eng W; Lund K; Paek D; Cockerell CJ
    Am J Dermatopathol; 2004 Jun; 26(3):217-21. PubMed ID: 15166510
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epidermal growth factor receptor (EGFR) expression in periocular and extraocular sebaceous carcinoma.
    Ivan D; Prieto VG; Esmaeli B; Wistuba II; Tang X; Lazar AJ
    J Cutan Pathol; 2010 Feb; 37(2):231-6. PubMed ID: 19614729
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sebaceous carcinoma: the great masquerader: emgerging concepts in diagnosis and treatment.
    Buitrago W; Joseph AK
    Dermatol Ther; 2008; 21(6):459-66. PubMed ID: 19076624
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sebaceous Carcinoma Arising From Heterotopic Salivary Gland Tissue in a Patient With Muir-Torre Syndrome.
    Syder NC; Rabi S; Hu JC
    Dermatol Surg; 2021 Dec; 47(12):1659-1660. PubMed ID: 34608093
    [No Abstract]   [Full Text] [Related]  

  • 32. Impaired Wnt/beta-catenin and protein patched homolog 1 signaling in extraocular sebaceous carcinoma: A clinical and histopathological study.
    Cheng AY; Lan J; Lee CH
    J Dermatol; 2022 Jun; 49(6):600-606. PubMed ID: 35318716
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical and Molecular Features of Skin Malignancies in Muir-Torre Syndrome.
    Simic D; Dummer R; Freiberger SN; Ramelyte E; Barysch MJ
    Genes (Basel); 2021 May; 12(5):. PubMed ID: 34065301
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A retrospective review of 1349 cases of sebaceous carcinoma.
    Dasgupta T; Wilson LD; Yu JB
    Cancer; 2009 Jan; 115(1):158-65. PubMed ID: 18988294
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Muir-Torre syndrome.
    Navi D; Wadhera A; Fung MA; Fazel N
    Dermatol Online J; 2006 Sep; 12(5):4. PubMed ID: 16962019
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Muir-Torre syndrome: a case of two brothers.
    Gáspár K; Veres I; Hunyadi J; Juhász I
    Int J Dermatol; 2006 Sep; 45(9):1124-6. PubMed ID: 16961537
    [No Abstract]   [Full Text] [Related]  

  • 37. Eyelid sebaceous carcinoma associated with Muir-Torre syndrome in two cases.
    Demirci H; Nelson CC; Shields CL; Eagle RC; Shields JA
    Ophthalmic Plast Reconstr Surg; 2007; 23(1):77-9. PubMed ID: 17237705
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dermoscopic features distinctive for extraocular sebaceous carcinoma.
    Horimoto K; Kato J; Sumikawa Y; Hida T; Kamiya T; Sato S; Takahashi H; Sawada M; Yamashita T; Uhara H
    J Dermatol; 2018 Apr; 45(4):487-490. PubMed ID: 29235655
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of Muir-Torre Syndrome on Survival in Patients With Sebaceous Carcinoma: A SEER Population-Based Study.
    Tripathi R; Bordeaux JS
    Dermatol Surg; 2019 Jan; 45(1):148-149. PubMed ID: 29578884
    [No Abstract]   [Full Text] [Related]  

  • 40. Sebaceous carcinoma arising in nevus sebaceus of Jadassohn: a clinicopathological study of five cases.
    Kazakov DV; Calonje E; Zelger B; Luzar B; Belousova IE; Mukensnabl P; Michal M
    Am J Dermatopathol; 2007 Jun; 29(3):242-8. PubMed ID: 17519621
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.